Sino Biological puts 3-day AI binder validation into market

Sino Biological launched 4RISE on November 13, 2026, promising cell-free protein expression in as little as three hours and sequence-to-AI-ready binding data in as little as three days.

Sino Biological describes the new service: “4RISE closes the gap between AI protein design and experimental proof by returning binding data in days.”

Sino Biological launched 4RISE as a high-throughput wet-lab validation service for AI-designed protein binders. The company says real-time API access will deliver structured results, including binding and kinetic measurements.

Under Sino Biological’s model, computational output becomes useful only after a team can express it, measure it and feed the result back into another design cycle.

What happens after AI designs a protein binder?

Sino Biological says AI-generated candidates must be produced and tested to confirm target-binding activity. Its documented workflow covers:

• Submission of the sequence and testing requirements.
• Expression and purification.
• Binding and kinetic analysis.
• Optional developability and functional validation.
• Structured data delivery with API access.

Sino Biological positions the output as experimental feedback for later research and design iterations. In plain terms, 4RISE adds the wet-lab evidence needed to rank AI-generated candidates.

Why does 4RISE favor cell-free expression?

Sino Biological’s XPressMAX cell-free protein synthesis platform supports miniproteins, VHHs, scFvs, Fabs, enzymes and cytokines. For formats requiring mammalian production, including full-length antibodies and Fc-fusion proteins, 4RISE offers HEK293 and CHO transient expression.

In a company-reported project involving more than 300 AI-designed minibinder variants, HEK293 expression succeeded for roughly 50–60% of candidates. Cell-free expression succeeded for more than 99%, after which the candidates underwent multi-target bio-layer interferometry analysis.

The company uses Carterra and Biacore surface plasmon resonance (SPR) and Octet bio-layer interferometry (BLI). Where supported by the assay design, Sino Biological says its affinity and kinetic tier can report KD, kon and koff for lead selection.

The company’s own figures make cell-free production the clearest efficiency advantage in the workflow.

What do the four validation tiers cost?

Sino Biological’s published service tiers separate crude screening from purified, quantitative characterization:

• Rapid Hit Discovery — from $67 per sequence: Cell-free expression and single-point SPR/BLI screening of crude supernatants.
• Comparative Binder Screening — from $112 per sequence: Purified candidates at controlled concentrations, followed by single-point SPR/BLI.
• Affinity & Kinetic Characterization — from $142 per sequence: Purified candidates analyzed across multiple concentrations.
• Specialized Binder Expression & Validation — custom quote: Mammalian expression with single- or multi-concentration binding analysis.

Standalone cell-free expression starts at $47 per sequence. Across the published tiers, the price rises from $67 to $142 as screening moves from crude supernatants to purified proteins analyzed across multiple concentrations.

What can the service test beyond binding?

Sino Biological lists more than 20 physicochemical assays, more than 1,000 protein bioactivity assays and more than 10 cell-based functional assays.

Developability options test thermal stability, aggregation, self-association, polyspecificity, hydrophobicity, expression and solubility. Functional options include neutralization, cell signaling, proliferation and enzyme-activity assays.

Sino Biological uses these options to extend evaluation from target binding to biological activity and subsequent research decisions. Customers can buy a binding readout or add evidence on stability, function and development risk.

How did Tencent AI Lab use 4RISE?

The service page says Sino Biological supported more than 200 AI-designed enzymes across three rounds of design, validation and iteration. The work included gene synthesis, cell-free expression, purification and in vitro functional validation.

Assays covered lysozyme activity, chitinase activity and high-temperature stability. Sino Biological says the experimental feedback helped Tencent AI Lab optimize its Ontology Reinforcement Iteration protein-design framework.

In plain terms, the three-round project used experimental measurements to guide the next design cycle.

How fast can projects move through the workflow?

In one company-reported validation project, direct SPR screening evaluated more than 200 AI-designed binders in cell-free supernatants without purification. The screen identified 11 binding-positive candidates and delivered gene-to-AI-ready data in three to four days.

A second company case study covered more than 2,000 de novo-designed scFv and VHH sequences. Gene synthesis, cell-free expression, purification and multi-target BLI analysis produced an initial delivery of purified antibodies and binding data in seven to eight days.

Sino Biological qualifies its three-day claim: the fastest turnaround applies to a particular sequence-to-binding-data workflow, while the larger purified-antibody project took longer. Assay scope and purification needs therefore sit at the center of any purchasing comparison.

For buyers, the next proof point is repeatability across customer libraries, because Sino Biological’s own cases range from three to four days for crude-supernatant screening to seven to eight days for purified antibodies.